Literature DB >> 21620648

Prevalence and predictors of sleep difficulty in a national cohort of women with primary breast cancer three to four months postsurgery.

Ben Colagiuri1, Søren Christensen, Anders B Jensen, Melanie A Price, Phyllis N Butow, Robert Zachariae.   

Abstract

CONTEXT: Mounting evidence suggests that many cancer patients suffer from sleep difficulty, but there is conflicting evidence regarding the prevalence and predictors of this adverse symptom.
OBJECTIVES: The present study investigated the prevalence and predictors of clinically significant sleep difficulty in women with primary breast cancer.
METHODS: Danish women (n=3343) with primary breast cancer completed the Pittsburgh Sleep Quality Index (PSQI) along with measures of depression, anxiety, physical activity/functioning, and health behaviors three to four months postsurgery. Data on disease status, treatment, and comorbidity were obtained from the Danish Cancer Cooperative Group and surgical departments, and information on sociodemographic factors and psychiatric history was obtained from Danish national longitudinal registries.
RESULTS: More than half (57.9%) of the women reported clinically significant sleep difficulty (PSQI >5). Multiple logistic regression identified seven significant predictors of sleep difficulty in the full sample. In order of strength, these were the following: more depressive symptoms, poorer physical functioning, older age, higher levels of trait anxiety, consuming more cigarettes, having undergone lumpectomy, and lower levels of physical activity. Subgroup analysis found that more depressive symptoms and poorer physical functioning were the only two predictors that were significant in both pre- and postmenopausal women.
CONCLUSION: These findings indicate that a high proportion of women with breast cancer experience sleep difficulty. Depression and poorer physical functioning appear to be robust predictors of sleep difficulty, whereas other predictors may depend on sample characteristics, including menopausal status. Copyright Â
© 2011 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21620648     DOI: 10.1016/j.jpainsymman.2011.02.012

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  21 in total

1.  Identification of subgroups of chemotherapy patients with distinct sleep disturbance profiles and associated co-occurring symptoms.

Authors:  Maria Tejada; Carol Viele; Kord M Kober; Bruce A Cooper; Steven M Paul; Laura B Dunn; Marilyn J Hammer; Fay Wright; Yvette P Conley; Jon D Levine; Christine Miaskowski
Journal:  Sleep       Date:  2019-10-09       Impact factor: 5.849

2.  Breast Cancer Collaborative Registry informs understanding of factors predicting sleep quality.

Authors:  Ann M Berger; Kevin A Kupzyk; Dilorom M Djalilova; Kenneth H Cowan
Journal:  Support Care Cancer       Date:  2018-08-15       Impact factor: 3.603

3.  Factors that shape preference for acupuncture or cognitive behavioral therapy for the treatment of insomnia in cancer patients.

Authors:  Sheila N Garland; Whitney Eriksen; Sarah Song; Joshua Dearing; Frances K Barg; Philip Gehrman; Jun J Mao
Journal:  Support Care Cancer       Date:  2018-02-08       Impact factor: 3.603

4.  The impact of breast cancer treatments on sleep quality 1 year after cancer diagnosis.

Authors:  Filipa Fontes; Susana Pereira; Ana Rute Costa; Marta Gonçalves; Nuno Lunet
Journal:  Support Care Cancer       Date:  2017-06-16       Impact factor: 3.603

5.  Mindfulness-Based Stress Reduction as a Stress Management Intervention for Cancer Care: A Systematic Review.

Authors:  Sarah E Rush; Manoj Sharma
Journal:  J Evid Based Complementary Altern Med       Date:  2016-08-11

6.  Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance.

Authors:  Christina Van Onselen; Bruce A Cooper; Kathryn Lee; Laura Dunn; Bradley E Aouizerat; Claudia West; Marylin Dodd; Steven Paul; Christine Miaskowski
Journal:  Support Care Cancer       Date:  2012-10       Impact factor: 3.603

7.  Symptom Trajectories Are Associated With Co-occurring Symptoms During Chemotherapy for Breast Cancer.

Authors:  Meagan Whisenant; Bob Wong; Sandra A Mitchell; Susan L Beck; Kathi Mooney
Journal:  J Pain Symptom Manage       Date:  2018-11-17       Impact factor: 3.612

8.  Distinct Trajectories of Fatigue and Sleep Disturbance in Women Receiving Chemotherapy for Breast Cancer.

Authors:  Meagan Whisenant; Bob Wong; Sandra A Mitchell; Susan L Beck; Kathi Mooney
Journal:  Oncol Nurs Forum       Date:  2017-11-01       Impact factor: 2.172

9.  Relationship between sleep and exercise as colorectal cancer survivors transition off treatment.

Authors:  Theresa Coles; Antonia V Bennett; Xianming Tan; Claudio L Battaglini; Hanna K Sanoff; Ethan Basch; Roxanne E Jensen; Bryce B Reeve
Journal:  Support Care Cancer       Date:  2018-02-22       Impact factor: 3.603

10.  Patient characteristics associated with sleep disturbance in breast cancer survivors.

Authors:  Chelsea G Ratcliff; Stephanie G Zepeda; Martica H Hall; Emily A Tullos; Shaelyn Fowler; Alejandro Chaoul; Amy Spelman; Banu Arun; Lorenzo Cohen
Journal:  Support Care Cancer       Date:  2020-09-22       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.